Dec 02, 2025 00:58
EVOK - Evoke Pharma, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 10.7 0.0 (0.0%) | --- | --- | 0.02 (0.19%) | --- | 0.0 (0.0%) | 0.02 (0.19%) | 0.02 (0.19%) |
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.62
- Diluted EPS:
- -0.62
- Basic P/E:
- -17.2581
- Diluted P/E:
- -17.2581
- RSI(14) 1m:
- 100.0
- VWAP:
- 10.7
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Dec 01, 2025 23:49
Nov 13, 2025 22:30
Nov 05, 2025 23:27
Nov 04, 2025 15:20
Oct 27, 2025 17:00
Aug 26, 2025 11:00
Aug 21, 2025 11:00
Aug 06, 2025 10:30
Nov 12, 2024 07:37